Document is current
Any future updates will be listed below
-
Authors
Huang, Yiquan
Zhou, Ziwei
Lin, Yifen
Zhang, Shaozhao
Xiong, Zhenyu
Liu, Menghui
Guo, Yue
Zhang, Wenjing
Zhuang, Xiaodong https://orcid.org/0000-0001-6508-8507
Liao, Xinxue https://orcid.org/0000-0001-7631-1866
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81870195)
National Natural Science Foundation of China (82070384)
National Natural Science Foundation of China (81900329)
Guangdong Science and Technology Department (2019A1515011582)
Guangdong Science and Technology Department (2021A1515011668)
Guangdong Science and Technology Department (2021A1515110266)
Guangdong Science and Technology Department (2019A1515011098)
Guangdong Science and Technology Department (2022A1515010416)
China Postdoctoral Science Foundation (2021TQ0386)
China Postdoctoral Science Foundation (2021M703738)
- License Information
-
More Information
Article History
Received: 16 May 2024
Revised: 27 April 2025
Accepted: 15 July 2025
First Online: 7 November 2025
Ethics approval and consent to participate
: This study involved human participants and was approved by institutional review boards at all participating institutions in the Atherosclerosis Risk in Communities (ARIC) study as well as by a review panel at the National Heart, Lung, and Blood Institute (NHLBI). The current analysis of the ARIC study data was approved by IEC for Clinical Research and Animal Trials of the First Affiliated Hospital of Sun Yat-Sen University (2020429). Participants provided written informed consent. All methods were performed in accordance with the relevant guidelines and regulations.
: The authors declare no competing interests.
